Follow
Laura Segalés Tañà
Laura Segalés Tañà
Verified email at estudiant.upf.edu
Title
Cited by
Cited by
Year
Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status
JLT Raquel Albero-González, Silvia Hernández-Llodrà, Nuria Juanpere, Marta ...
Virchows Archiv, 2019
242019
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression
S Hernández-Llodrà, N Juanpere, S de Muga, M Lorenzo, J Gil, ...
Oncotarget 8 (43), 74106, 2017
202017
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG ‐rearranged prostate cancer
JLT Silvia Hernández‐Llodrà, Laura Segalés, Ainara Safont, Nuria Juanpere ...
The Prostate 79 (10), 1156-1165, 2019
172019
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence
S Hernández‐Llodrà, L Segales, N Juanpere, T Marta Lorenzo, M Salido, ...
The Prostate 81 (16), 1267-1277, 2021
92021
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome
SHL Laura Segalés, Nuria Juanpere, Marta Lorenzo, Raquel Albero-González ...
Virchows Archiv, 2019
92019
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer
L Segalés, N Juanpere, N Gallarín, M Lorenzo, D López, J Perera-Bel, ...
Virchows Archiv, 1-10, 2023
12023
ERG expression in HGPIN is a marker of coexisting adenocarcinoma-a pilot study in totally embedded cystoprostatectomy specimens
N Juanpere Rodero, A Martinez, M Lorenzo, L Segales, S Hernandez, ...
VIRCHOWS ARCHIV 477, S161-S161, 2020
2020
SPOP and CHD1 Alterations in Prostate Cancer. Relationship with PTEN Loss and Grade Group Classification
S Hernández-Llodrà, L Segalés, N Juanpere, M Lorenzo, L Fumadó, ...
109th United States and Canada Academy of Pathologists annual Meeting. Los …, 2020
2020
ETS2 Loss of Expression in Prostate Cancer
L Segalés, J Lloreta, N Juanpere, M Lorenzo, L Fumadó, L Cecchinni, ...
109th United States and Canada Academy of Pathologists annual Meeting. Los …, 2020
2020
SPOP and FOXA1 alterations in prostate cancer. Relationship with ERG overexpression and grade group classification.
LCJL Silvia Hernández-Llodrà, Laura Segalés, Ainara Safont, Nuria Juanpere ...
16th ASEICA International Congress. Valencia, 5-8 of November, 2018., 2018
2018
Strong ETV1 expression is associated with PSA recurrence in prostate cancer, in spite of low ETS gene overexpression in GG5 tumors.
SHL Laura Segalés, Nuria Juanpere, Marta Lorenzo, Lluís Fumadó, Lluís ...
16th ASEICA International Congress. Valencia, 5-8 of November, 2018., 2018
2018
SPOP mRNA downregulation is associated with the presence of the TMPRSS2-ERG fusion and PTEN loss on Prostate Cancer.
BLJL Silvia Hernández-Llodrà, Laura Segalés, Nuria Juanpere, Marta Lorenzo ...
107th United States and Canada Academy of Pathologists annual Meeting …, 2018
2018
ETS genes (ERG, ETV1, ETV4 and ETV5) overexpression and PTEN loss in Prostate Cancer.
SHL Laura Segalés, Nuria Juanpere, Sílvia de Muga, Marta Lorenzo, Lluis ...
107th United States and Canada Academy of Pathologists annual Meeting …, 2018
2018
Overexpression of ETS genes (ERG, ETV1, ETV4 and ETV5) in Prostate Cancer.
SHL Laura Segalés, Nuria Juanpere, Sílvia de Muga, Marta Lorenzo, Lluis ...
1st DCEXS-UPF PhD Students' Symposium. Barcelona, 24 of November, 2017., 2017
2017
FGFR3 mutations analysis in urine samples can be used as a marker of Bladder Cancer detection.
JLSHL Francesc Alameda, Laura Segalés, Marta Lorenzo, Núria Juanpere ...
29th European Congress of Pathology. Amsterdam, 2 – 6 of September, 2017., 2017
2017
Overexpression of ETS genes (ERG, ETV1, ETV4 and ETV5) in Prostate Cancer.
LCJL Sílvia Hernández-Llodrà, Laura Segalés, Silvia de Muga, Nuria Juanpere ...
29th European Congress of Pathology. Amsterdam, 2 – 6 of September, 2017., 2017
2017
High ETV1 levels are associated with shorter PSA-progression time in prostate cancer, but ETS overexpression is lower in GG5 tumors
L Segalés, N Juanpere, M Lorenzo, L Fumadó, L Cecchini, J Lloreta-Trull, ...
The system can't perform the operation now. Try again later.
Articles 1–17